Prof. Jens Bedke (DE) talks about two key topics from this year's EMUC24 kidney cancer sessions: the role of cytoreductive nephrectomy, and the SUNNIFORECAST trial (prospective randomised phase 2 trial of ipilimumab + nivolumab versus standaard of care in non-clear cell RCC.)

This informative episode was recorded at the 16th European Multidisciplinary Congress on Urological Cancers (EMUC24) in Lisbon, Portugal. 

For more EAU podcasts, please go to your favourite podcast app and subscribe to our podcast channel for regular updates: Apple Podcasts, Spotify, EAU YouTube channel.